TY  - CHAP
M1  - Book, Section
TI  - Ibritumomab Tiuxetan
A1  - Ciccone, Charles D.
Y1  - 2016
N1  - 
T2  - Davis's Drug Guide for Rehabilitation Professionals
AB  - ibritumomab  tiuxetan  (i-bri-too-mo-mab  tye-uks-i-tan)ZevalinClassificationTherapeutic:  antineoplasticsPharmacologic:  monoclonal  antibodies,  radioisotopes  
SN  - 
PB  - F. A. Davis Company
CY  - New York, NY
Y2  - 2024/04/20
UR  - fadavispt.mhmedical.com/content.aspx?aid=1134172096
ER  -